Free Trial

Bone Biologics (BBLG) Competitors

Bone Biologics logo
$0.82 -0.02 (-2.59%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.84 +0.02 (+1.83%)
As of 03/28/2025 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BBLG vs. BTCY, LYRA, SSKN, IINN, NURO, WOK, PAVM, STRR, BSGM, and MHUA

Should you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Biotricity (BTCY), Lyra Therapeutics (LYRA), STRATA Skin Sciences (SSKN), Inspira Technologies Oxy B.H.N. (IINN), NeuroMetrix (NURO), WORK Medical Technology Group LTD Ordinary Shares (WOK), PAVmed (PAVM), Star Equity (STRR), BioSig Technologies (BSGM), and Meihua International Medical Technologies (MHUA). These companies are all part of the "medical equipment" industry.

Bone Biologics vs.

Bone Biologics (NASDAQ:BBLG) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings, community ranking and profitability.

Bone Biologics has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bone Biologics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Bone Biologics has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Bone Biologics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bone BiologicsN/A -124.71% -111.64%
Biotricity -80.42%N/A -188.47%

In the previous week, Bone Biologics had 2 more articles in the media than Biotricity. MarketBeat recorded 2 mentions for Bone Biologics and 0 mentions for Biotricity. Bone Biologics' average media sentiment score of 1.43 beat Biotricity's score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.

Company Overall Sentiment
Bone Biologics Positive
Biotricity Neutral

34.3% of Bone Biologics shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 7.5% of Bone Biologics shares are held by company insiders. Comparatively, 10.1% of Biotricity shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bone Biologics and Biotricity both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Bone BiologicsN/AN/A
BiotricityOutperform Votes
No Votes
Underperform Votes
2
100.00%

Bone Biologics has higher earnings, but lower revenue than Biotricity.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bone BiologicsN/AN/A-$8.95MN/AN/A
Biotricity$12.06M0.86-$14.09M-$1.08-0.39

Summary

Bone Biologics beats Biotricity on 6 of the 11 factors compared between the two stocks.

Remove Ads
Get Bone Biologics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBLG vs. The Competition

MetricBone BiologicsSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$2.68M$8.83B$5.63B$7.84B
Dividend YieldN/A1.42%5.33%4.01%
P/E RatioN/A18.1023.5518.73
Price / SalesN/A66.77388.1990.75
Price / CashN/A19.6738.1734.64
Price / Book0.115.416.894.23
Net Income-$8.95M$284.66M$3.20B$247.47M
7 Day Performance-6.82%-2.68%-3.06%-2.29%
1 Month Performance-7.73%-5.35%1.51%-5.81%
1 Year Performance-61.50%-23.28%9.37%-0.96%

Bone Biologics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBLG
Bone Biologics
1.2079 of 5 stars
$0.82
-2.6%
N/A-61.5%$2.68MN/A0.002Short Interest ↓
Positive News
Gap Down
BTCY
Biotricity
N/A$0.44
-7.7%
N/A-71.8%$10.90M$12.06M-0.4140
LYRA
Lyra Therapeutics
2.6528 of 5 stars
$0.16
-6.8%
$4.50
+2,659.0%
-97.7%$10.75M$1.53M-0.1150Short Interest ↑
SSKN
STRATA Skin Sciences
2.8811 of 5 stars
$2.57
-4.1%
$6.00
+133.5%
-28.8%$10.72M$32.68M-0.97120Earnings Report
Short Interest ↑
News Coverage
Gap Down
IINN
Inspira Technologies Oxy B.H.N.
0.8 of 5 stars
$0.77
-0.6%
N/A-60.8%$9.72MN/A0.0020
NURO
NeuroMetrix
0.8722 of 5 stars
$4.55
+0.8%
N/A+4.2%$9.33M$3.77M-0.9920Analyst Forecast
Short Interest ↓
News Coverage
WOK
WORK Medical Technology Group LTD Ordinary Shares
N/A$0.62
-3.1%
N/AN/A$9.05M$11.51M0.00226Gap Down
PAVM
PAVmed
4.4495 of 5 stars
$0.80
-1.2%
$19.00
+2,275.0%
-65.0%$8.86M$4.03M-0.1890Short Interest ↓
News Coverage
STRR
Star Equity
1.1784 of 5 stars
$2.67
+10.3%
N/A-43.2%$8.59M$50.38M-1.04460Analyst Revision
Positive News
Gap Up
High Trading Volume
BSGM
BioSig Technologies
1.8134 of 5 stars
$0.49
-9.4%
$2.75
+456.9%
-10.7%$8.51M$39,000.000.0050News Coverage
High Trading Volume
MHUA
Meihua International Medical Technologies
2.0812 of 5 stars
$0.34
-1.0%
N/A-53.9%$8.49M$94.25M0.00620Short Interest ↓
Remove Ads

Related Companies and Tools


This page (NASDAQ:BBLG) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners